A detailed history of Barclays PLC transactions in Exscientia PLC stock. As of the latest transaction made, Barclays PLC holds 247 shares of EXAI stock, worth $1,195. This represents 0.0% of its overall portfolio holdings.

Number of Shares
247
Previous 247 -0.0%
Holding current value
$1,195
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$4.26 - $6.0 $1,052 - $1,482
247 New
247 $1,000
Q1 2023

May 04, 2023

BUY
$5.3 - $10.93 $3,063 - $6,317
578 New
578 $3,000

Others Institutions Holding EXAI

About Exscientia plc


  • Ticker EXAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 122,461,000
  • Market Cap $593M
  • Description
  • Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on s...
More about EXAI
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.